MMP19 and type 2 diabetes mellitus: If the probabilities of treatment with statins and RASi had been the same as in the well-controlled group on GLDT, the excess absolute risk of 5 year MACE could be reduced by 2.6% (95% CI 1.6, 3.5) in the group with persistent type 2 diabetes not on GLDT and by 1.4% (95% CI 0.6, 2.1) in the remission group not on GLDT (ESM Fig. 9).